hemostasis clinicians

Scroll to Explore

Clinical Value


Scientific literature shows that the use of TEG technology can help clinicians to improve patient outcomes and reduce costs by analyzing the coagulation state of a blood sample. By individualizing goal-directed coagulation management, it is possible to reduce inappropriate blood transfusions, and stratify patients according to their risk of bleeding and/or thrombotic complications. There is consequently a great opportunity to achieve substantial cost savings with a goal-directed TEG program.

 

Reduce
Blood Product Use


The TEG® System is intended to reduce the use of unnecessary blood products and reduce thrombotic complications leading to improved patient outcomes.

Within the hospital, one in seven patients receives blood products, with a massive associated cost in both lives and dollars, as transfusions are associated with a dramatically increased incidence of death, heart attack and stroke. Using TEG to monitor a patient’s hemostasis during surgery allows for a reduction in blood product usage by providing clinicians with information to help determine which specific blood products are needed to stop bleeding, and accurately identifies the need for re-operations by ruling out a coagulopathic cause of bleeding.

 

Improve
Adequate Use of Drug Therapy


Anticoagulant or antiplatelet therapy is often stopped a few days before cardiovascular surgery to reduce the risk of perioperative bleeding while potentially increasing the risk of a thromboembolic event in the preoperative period.

To minimize patient risk and time to schedule interventions, TEG® PlateletMapping can be used to assess platelet function and predict thrombotic events post-operatively or after percutaneous coronary intervention (PCI). For example, the use of TEG has been shown to effectively lead to an earlier scheduling of CABG procedure with a reduction in time to surgery. In addition, monitoring patients with TEG can help identify individuals who have failed to adequately stop antiplatelet therapy prior to non-cardiac surgery, preventing unnecessary cancellation while minimizing patient risk.

 

Stratification
of the Risk of Thrombosis


TEG® can help to predict thrombotic complications. Two separate studies have demonstrated an association between TEG results and ischemic events or thrombotic complications in cardiac surgery. Furthermore, TEG has been described to be more sensitive than Conventional Coagulation Tests for the identification of hypercoagulable states which are predictive of thromboembolic events including pulmonary embolism.